Dedicated to improving the outcome for heart failure patients with Central Sleep Apnea.

The remedē® System – an implantable stimulation therapy solution

Central Sleep Apnea and Heart Failure

Central Sleep Apnea disturbs the normal breathing pattern during sleep and has an adverse effect on overall cardiovascular health. Central Sleep Apnea patients may also suffer from heart failure and experience arrhythmias, decreased quality of life, and increased mortality rates.


I’m a Patient…
I’m a Medical Professional…

How Our remedē® System Works

The remedē® System is designed to improve cardiovascular health by restoring a more regular breathing pattern during sleep…. one breath at a time™. Read More…


Founded in 2006 and headquartered near Minneapolis, Minnesota, Respicardia® is dedicated to improving the lives of heart failure patients by developing implantable therapies designed to improve respiratory rhythm management and cardiovascular health. Read More…


Respicardia, Inc.
12400 Whitewater Dr., Suite 150
Minnetonka, MN 55343 USA
See Map
Phone: +1-952-540-4470
E-mail: info@respicardia.com
©2015 Respicardia, Inc. CAUTION: Investigational Device. Limited by Federal (United States) Law to investigational use.